TrialFrontiers in cellular and infection microbiology2025

Effects of short-chain fatty acid-producing probiotic metabolites on symptom relief and intestinal barrier function in patients with irritable bowel syndrome: a double-blind, randomized controlled trial.

Erfeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.